Joseph Hargett

Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street JournalThe New York TimesMoney Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Monday’s Vital Data: Alibaba Group Holding Ltd (BABA), Amazon.com, Inc. (AMZN) and Tesla Inc (TSLA)

Alibaba (BABA) closes in on China listing, Amazon.com (AMZN) trims Whole Foods workforce and Tesla (TSLA) Model 3 production ramps up.

Betting Bullish on a Bank of America Corp. Stock Bounce

Bank of America is at the mercy of panicking investors right now. But BAC stock should easily survive a trade war and gain ground on faster pace to Fed interest rate hikes.

Friday’s Vital Data: Micron Technology, Inc. (MU), Apple Inc. (AAPL) and Facebook, Inc. (FB)

Micron (MU) options traders caught by post-earnings plunge, Apple (AAPL) gets a bullish Morgan Stanley note and Facebook (FB) pressured by #DeleteFacebook.

How to Trade Adobe Systems Incorporated Stock at All-Time Highs

Adobe stock is trading in the clouds, but it's overbought and poised for a retreat. Here's how you can either profit from the decline or name your price for a long-term position.

Wednesday’s Vital Data: General Electric Company (GE), Twitter Inc (TWTR) and Nvidia Corporation (NVDA)

General Electric (GE) options jump on 8-year low, Twitter (TWTR) smacked lower by Facebook (FB) fallout and Nvidia (NVDA) unveils RTX ray-tracing tech.

Buy the Bottom in Biogen Inc. Stock for a 100% Return

Biogen stock is ready to rebound from a dreadful February beating. Here's how to profit from a resurgent BIIB.

Tuesday’s Vital Data: Facebook Inc (FB), Ford Motor Company (F) and Oracle Corporation (ORCL)

Facebook (FB) options spike on Cambridge Analytica, Ford (F) invests in 3D metal printing company and Oracle (ORCL) call option bulls smacked on earnings.

Monday’s Vital Data: Micron Technology, Inc. (MU), Apple Inc. (AAPL) and Amazon.com, Inc. (AMZN)

Micron Technology (MU) options rose on a rush of bullish analyst commentary, Apple (AAPL) makes its own screens and Amazon (AMZN) hires ex-FDA official.

Friday’s Vital Data: Alibaba Group Holding Ltd (BABA), Monsanto Company (MON) and Tesla Inc (TSLA)

Alibaba (BABA) options jump on potential Shanghai listing, Monsanto (MON) options surged on Bayer AG deal scrutiny and Tesla (TSLA) production issues, again.

Mylan N.V. Stock Is Headed Back Down to $40

Despite a wealth of bullish news since the beginning of March, MYL stock remains capped by this key trendline ... and it will send Mylan shares lower as a result.